Cargando…

Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers

BACKGROUND: Recently, we reported the feasibility of indocyanine green (ICG) near-infrared fluorescence (NIRF) imaging to identify extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC) in pediatric patients. This paper aimed to describe the use of a new technology, RUBINA™, to perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Ciro, Alberti, Daniele, Settimi, Alessandro, Pecorelli, Silvia, Boroni, Giovanni, Montanaro, Beatrice, Escolino, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523512/
https://www.ncbi.nlm.nih.gov/pubmed/34231069
http://dx.doi.org/10.1007/s00464-021-08596-7
_version_ 1784585316928061440
author Esposito, Ciro
Alberti, Daniele
Settimi, Alessandro
Pecorelli, Silvia
Boroni, Giovanni
Montanaro, Beatrice
Escolino, Maria
author_facet Esposito, Ciro
Alberti, Daniele
Settimi, Alessandro
Pecorelli, Silvia
Boroni, Giovanni
Montanaro, Beatrice
Escolino, Maria
author_sort Esposito, Ciro
collection PubMed
description BACKGROUND: Recently, we reported the feasibility of indocyanine green (ICG) near-infrared fluorescence (NIRF) imaging to identify extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC) in pediatric patients. This paper aimed to describe the use of a new technology, RUBINA™, to perform intra-operative ICG fluorescent cholangiography (FC) in pediatric LC. METHODS: During the last year, ICG-FC was performed during LC using the new technology RUBINA™ in two pediatric surgery units. The ICG dosage was 0.35 mg/Kg and the median timing of administration was 15.6 h prior to surgery. Patient baseline, intra-operative details, rate of biliary anatomy identification, utilization ease, and surgical outcomes were assessed. RESULTS: Thirteen patients (11 girls), with median age at surgery of 12.9 years, underwent LC using the new RUBINA™ technology. Six patients (46.1%) had associated comorbidities and five (38.5%) were practicing drug therapy. Pre-operative workup included ultrasound (n = 13) and cholangio-MRI (n = 5), excluding biliary and/or vascular anatomical anomalies. One patient needed conversion to open surgery and was excluded from the study. The median operative time was 96.9 min (range 55–180). Technical failure of intra-operative ICG-NIRF visualization occurred in 2/12 patients (16.7%). In the other cases, ICG-NIRF allowed to identify biliary/vascular anatomic anomalies in 4/12 (33.3%), including Moynihan's hump of the right hepatic artery (n = 1), supravescicular bile duct (n = 1), and short cystic duct (n = 2). No allergic or adverse reactions to ICG, post-operative complications, or reoperations were reported. CONCLUSION: Our preliminary experience suggested that the new RUBINA™ technology was very effective to perform ICG-FC during LC in pediatric patients. The advantages of this technology include the possibility to overlay the ICG-NIRF data onto the standard white light image and provide surgeons a constant fluorescence imaging of the target anatomy to assess position of critical biliary structures or presence of anatomical anomalies and safely perform the operation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08596-7.
format Online
Article
Text
id pubmed-8523512
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85235122021-11-04 Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers Esposito, Ciro Alberti, Daniele Settimi, Alessandro Pecorelli, Silvia Boroni, Giovanni Montanaro, Beatrice Escolino, Maria Surg Endosc Dynamic Manuscript BACKGROUND: Recently, we reported the feasibility of indocyanine green (ICG) near-infrared fluorescence (NIRF) imaging to identify extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC) in pediatric patients. This paper aimed to describe the use of a new technology, RUBINA™, to perform intra-operative ICG fluorescent cholangiography (FC) in pediatric LC. METHODS: During the last year, ICG-FC was performed during LC using the new technology RUBINA™ in two pediatric surgery units. The ICG dosage was 0.35 mg/Kg and the median timing of administration was 15.6 h prior to surgery. Patient baseline, intra-operative details, rate of biliary anatomy identification, utilization ease, and surgical outcomes were assessed. RESULTS: Thirteen patients (11 girls), with median age at surgery of 12.9 years, underwent LC using the new RUBINA™ technology. Six patients (46.1%) had associated comorbidities and five (38.5%) were practicing drug therapy. Pre-operative workup included ultrasound (n = 13) and cholangio-MRI (n = 5), excluding biliary and/or vascular anatomical anomalies. One patient needed conversion to open surgery and was excluded from the study. The median operative time was 96.9 min (range 55–180). Technical failure of intra-operative ICG-NIRF visualization occurred in 2/12 patients (16.7%). In the other cases, ICG-NIRF allowed to identify biliary/vascular anatomic anomalies in 4/12 (33.3%), including Moynihan's hump of the right hepatic artery (n = 1), supravescicular bile duct (n = 1), and short cystic duct (n = 2). No allergic or adverse reactions to ICG, post-operative complications, or reoperations were reported. CONCLUSION: Our preliminary experience suggested that the new RUBINA™ technology was very effective to perform ICG-FC during LC in pediatric patients. The advantages of this technology include the possibility to overlay the ICG-NIRF data onto the standard white light image and provide surgeons a constant fluorescence imaging of the target anatomy to assess position of critical biliary structures or presence of anatomical anomalies and safely perform the operation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08596-7. Springer US 2021-07-06 2021 /pmc/articles/PMC8523512/ /pubmed/34231069 http://dx.doi.org/10.1007/s00464-021-08596-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Dynamic Manuscript
Esposito, Ciro
Alberti, Daniele
Settimi, Alessandro
Pecorelli, Silvia
Boroni, Giovanni
Montanaro, Beatrice
Escolino, Maria
Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title_full Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title_fullStr Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title_full_unstemmed Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title_short Indocyanine green (ICG) fluorescent cholangiography during laparoscopic cholecystectomy using RUBINA™ technology: preliminary experience in two pediatric surgery centers
title_sort indocyanine green (icg) fluorescent cholangiography during laparoscopic cholecystectomy using rubina™ technology: preliminary experience in two pediatric surgery centers
topic Dynamic Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523512/
https://www.ncbi.nlm.nih.gov/pubmed/34231069
http://dx.doi.org/10.1007/s00464-021-08596-7
work_keys_str_mv AT espositociro indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT albertidaniele indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT settimialessandro indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT pecorellisilvia indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT boronigiovanni indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT montanarobeatrice indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters
AT escolinomaria indocyaninegreenicgfluorescentcholangiographyduringlaparoscopiccholecystectomyusingrubinatechnologypreliminaryexperienceintwopediatricsurgerycenters